Skip to content
Screener

ICU Medical ICUI Q4 2025 Annual earnings

Reported February 19, 2026 · After market close

Revenue$535.9MBeat by $5.4M
EPS$1.91Beat by $0.23
Revenue estimate$530.6M
EPS estimate$1.68

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$552.1M
EPS estimate$2.13

Financials

Q4 2025

Income statement

See full
Revenue$540.7M-14.1%
Gross profit$203.0M-10.7%
Operating income$5.6M-85.0%

Balance sheet

See full
Cash & equivalents$308.0M-0.2%
Total debt$1.4B-19.3%
Total equity$2.1B+8.1%
Total assets$4.1B-3.6%

Cash flow

See full
Operating cash flow$60.6M+50.8%
CapEx$24.6M+2.3%
Free cash flow$36.0M+123%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$3.52B-7.3%
Enterprise value$4.58B-11.6%
P/S1.6×0.0×

Profitability

See full
Gross margin36.8%+2.2pp
Operating margin1.9%+0.1pp
FCF margin4.5%-0.7pp

Returns & leverage

See full
Debt / equity0.6×-0.2×
Current ratio2.4×-0.2×

FAQ

When did ICU Medical report Q4 2025 earnings?
ICU Medical (ICUI) reported Q4 2025 earnings on February 19, 2026 after market close.
What were ICU Medical's Q4 2025 revenue and EPS?
ICU Medical reported revenue of $535.9M and eps of $1.91 for Q4 2025.
Did ICU Medical beat estimates in Q4 2025?
Revenue beat the consensus estimate of $530.6M by $5.4M. EPS beat the consensus estimate of $1.68 by $0.23.
How did ICU Medical's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 14.9% from $629.8M a year earlier and eps declined 9.5% from $2.11.
Where can I find ICU Medical's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000883984-26-000007) and the 10-K periodic report (0000883984-26-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.